4-PYRIMIDINSULFAMIDDERIVAT

European patent · EP2190837 · In force

Register entry

Publication number
EP2190837
Application number
EP08807330
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 15, 2008
Published
Jun 2, 2010
Granted
Aug 15, 2012
Protection ends at the latest
Aug 14, 2028
Next annual fee due
Aug 31, 2027
IPC classes
C07D 403/12 (2006.01)
A61K 31/506 (2006.01)
A61P 9/00 (2006.01)
A61P 25/00 (2006.01)
A61P 3/10 (2006.01)
Priority
WO PCT/IB2007/053292 17.08.2007
WO PCT/IB2008/052571 26.06.2008
PCT application
PCT/IB2008/053282 15.08.2008
PCT publication
WO2009/024906 26.02.2009
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Aprocitentanum

C02190837/01 · Medicine · Granted · Protection from Aug 15, 2028 to Aug 14, 2033

Authorisation 70047 (Swissmedic, Sep 18, 2025)

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  7. Sep 14, 2017

    Transferred

    Owner
    Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil → Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123 Allschwil

    Published in Swissreg on 14.09.2017

  8. Aug 15, 2012

    Granted

    Published in Swissreg on 15.08.2012

Parties

Holder

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91, 4123 Allschwil

Inventor

BOLLI, Martin

CH-4123 Allschwil

BOSS, Christoph

CH-4123 Allschwil

TREIBER, Alexander

CH-4123 Allschwil

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.